# 72266-147-10 · Etomidate Injection · Gland Pharma Limited — FDA drug shortage duration tracker For 72266-147-10 · Etomidate Injection · Gland Pharma Limited, package ndc is 72266-147-10; generic name is Etomidate Injection; manufacturer is Gland Pharma Limited; status is Current; availability now is Available, recorded from its source on 2026-09-01. - **Package NDC:** 72266-147-10 _(verified: appears in the quote below)_ - **Generic name:** Etomidate Injection _(verified: appears in the quote below)_ - **Manufacturer:** Gland Pharma Limited _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Available _(verified: appears in the quote below)_ - **FDA note:** Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. _(verified: appears in the quote below)_ - **Initial posting date:** 10/05/2022 _(verified: appears in the quote below)_ - **Last update date:** 07/22/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 1427 _(our reading, not quoted from the source)_ - **Dosage form:** Injection _(verified: appears in its own passage below)_ - **Therapeutic category:** Anesthesia _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "10/05/2022", "package_ndc": "72266-147-10", "generic_name": "Etomidate Injection", "contact_info": "833-291-9645", "availability": "Available", "related_info": "Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645." ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "07/22/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)", "company_name": "Gland Pharma Limited", "status": "Current" ### Status > "update_date": "07/22/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)", "company_name": "Gland Pharma Limited", "status": "Current" ### Last update date > "update_date": "07/22/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)", "company_name": "Gland Pharma Limited", "status": "Current" ### Dosage form > "update_date": "07/22/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)", "company_name": "Gland Pharma Limited", "status": "Current" ### Therapeutic category > "update_date": "07/22/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)", "company_name": "Gland Pharma Limited", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-01. Review by: 2026-09-04. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).